Premium
Optimum chemotherapy regimens for neoadjuvant therapy of hepatic colorectal metastases
Author(s) -
Davies Janine M.,
Goldberg Richard M.
Publication year - 2010
Publication title -
journal of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.201
H-Index - 111
eISSN - 1096-9098
pISSN - 0022-4790
DOI - 10.1002/jso.21653
Subject(s) - medicine , colorectal cancer , neoadjuvant therapy , chemotherapy , oncology , hepatectomy , disease , resection , safer , medical therapy , systemic therapy , surgical resection , cancer , surgery , breast cancer , computer security , computer science
Abstract Resection of metastatic colorectal cancer hepatic lesions has gained support as surgical advances have made resections safer. Subsequently, the use of neoadjuvant therapy to cytoreduce tumors coupled with improved medical therapy has enhanced resection rates leading to improved outcomes. In “unresectable” disease, the addition of biologic therapies has further enhanced antitumor response, resulting in successful disease resection in certain patients. This review examines approaches to the neoadjuvant management of colorectal liver metastases with systemic therapies. J. Surg. Oncol. 2010;102:946–954. © 2010 Wiley‐Liss, Inc.